Systematic Review and Critical Analysis of Cost Studies Associated with Parkinson’s Disease
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease worldwide, affecting more than four million people. Typically, it affects individuals above 45, when they are still productive, compromising both aging and quality of life. Therefore, the cost of the disease must be iden...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2017/3410946 |